November 3, 2020 -- ImmunoPrecise Antibodies and artificial intelligence (AI) research institute Mila have formed a partnership to collaborate on research and talent development initiatives for antibody-based therapeutics.
Specifically, the partnership will apply AI to unexplored datasets generated by ImmunoPrecise's therapeutic antibody discovery platforms to help the design of new therapeutics against life-threatening diseases, according to the companies.